Predictors of warfarin therapeutic dose across thromboembolic indications: an exploratory early clinical evaluation study using machine learning-integrated explainable artificial intelligence and Bayesian models
Expert Review of Clinical Pharmacology · 03.06.2026 · 19 (6) · 587-600
DOI: 10.1080/17512433.2026.2682286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Expert Review of Clinical Pharmacology, online erschienen am 01.06.2026. Verfasst von Kannan Sridharan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain. Hauptthemen laut MEDLINE: Warfarin, Machine Learning, Anticoagulants, Thromboembolism. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.
- Bahrain Defence Force Royal Medical Services, Riffa, Kingdom of Bahrain.
ORCID-Profile: Kannan Sridharan
Zitieren
APA
Sridharan, K., & Sivaramakrishnan, G. (2026). Predictors of warfarin therapeutic dose across thromboembolic indications: an exploratory early clinical evaluation study using machine learning-integrated explainable artificial intelligence and Bayesian models. Expert Review of Clinical Pharmacology, 19(6), 587-600. https://doi.org/10.1080/17512433.2026.2682286
Vancouver
Sridharan K, Sivaramakrishnan G. Predictors of warfarin therapeutic dose across thromboembolic indications: an exploratory early clinical evaluation study using machine learning-integrated explainable artificial intelligence and Bayesian models. Expert Review of Clinical Pharmacology. 2026;19(6):587-600. doi:10.1080/17512433.2026.2682286
BibTeX
@article{Sridharan2026,
author = {Sridharan, Kannan and Sivaramakrishnan, Gowri},
title = {Predictors of warfarin therapeutic dose across thromboembolic indications: an exploratory early clinical evaluation study using machine learning-integrated explainable artificial intelligence and Bayesian models},
journal = {Expert Review of Clinical Pharmacology},
year = {2026},
volume = {19},
number = {6},
pages = {587--600},
doi = {10.1080/17512433.2026.2682286}
}
EUVIMED